Skip to main content
. 2013 Dec 6;8(12):e79769. doi: 10.1371/journal.pone.0079769

Figure 5. Kaplan–Meier 5-year PFS and OS curves for ovarian cancer patients stratified by four pathological parameters of interest.

Figure 5

(A) MUC2 expression level, low (immunostaining -/+) vs. high (immunostaining ++/+++). (B) M1/M2 ratio, lower vs. higher than the mean value. (C) COX-2+ TAM density, lower vs. higher than the mean value. (D) COX-2+ cancer cell density, lower vs. higher than the mean value. PFS, progression-free survival. OS, overall survival.